Pierre Lévy

The economic cost of obesity: the French situation.

Émile Lévy, Pierre Lévy, C. Le Pen et al. · PubMed · 1995 · 157 citations

Agriculture, Economics, Pharmacoeconomics +6

Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France

C. Chouaïd, L. Bensimon, E. Clay et al. · Lung Cancer · 2018 · 71 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Nursing aides and patient violence

Pierre Lévy, Peter Hartocollis · American Journal of Psychiatry · 1976 · 68 citations

Nursing, Mental Health Nursing, Psychiatry +12

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

Joris R. de Groot, Thomas W. Weiss, Peter J. Kelly et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2020 · 59 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +16

Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France

S. Druais, A. Doutriaux, M. Cognet et al. · PharmacoEconomics · 2016 · 52 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17